AlbertMJ.Beyond continuationism: Climate change, economic growth, and the future of world (dis)order. Cambridge Rev Int Aff, 2020; doi: 10.1080/09557571.2020.1825334.
2.
Al-TaieA, DenkdemirFR, ShariefZ, et al.The long view on COVID-19 theranostics and oral antivirals: Living with endemic disease and lessons from molnupiravir. OMICS, 2022; 26(6):324–328; doi: 10.1089/omi.2022.0045.
3.
CongY, EndoT.Multi-omics and artificial intelligence-guided drug repositioning: Prospects, challenges, and lessons learned from COVID-19. OMICS, 2022; 26(7):361–371; doi: 10.1089/omi.2022.0068.
4.
CostanzoM, CaterinoM, FedeleR, et al.COVIDomics: The proteomic and metabolomic signatures of COVID-19. Int J Mol Sci, 2022; 23(5):2414; doi: 10.3390/ijms23052414.
5.
HuangF, ChenL, GuoW, et al.Identifying COVID-19 severity-related SARS-CoV-2 mutation using a machine learning method. Life (Basel), 2022; 12(6):806; doi: 10.3390/life12060806.
6.
LinB, WuS.COVID-19 (coronavirus disease 2019): Opportunities and challenges for digital health and the internet of medical things in China. OMICS, 2020; 24(5):231–232; doi: 10.1089/omi.2020.0047.
7.
MaJ, DengY, ZhangM, et al.The role of multi-omics in the diagnosis of COVID-19 and the prediction of new therapeutic targets. Virulence, 2022; 13(1):1101–1110; doi: 10.1080/21505594.2022.2092941.
8.
ÖzdemirV.Phenomics 2.0: Real-world real-time patient outcomes measured by the internet of pharmaceutical things. OMICS, 2020; 24(3):119–121; doi: 10.1089/omi.2020.0015.
9.
ÖzdemirV.All things digital transformation: Health care, disinformation, big data, and death. OMICS, 2022; 26(2):75–76; doi: 10.1089/omi.2021.0226.
10.
ÖzdemirV, SpringerS.Decolonizing knowledge upstream: New ways to deconstruct and fight disinformation in an era of COVID-19, extreme digital transformation, and climate emergency. OMICS, 2022; 26(5):247–269; doi: 10.1089/omi.2022.0041.
